Case presentation and management of Lyme disease patients: a 9-year retrospective analysis in France
暂无分享,去创建一个
E. Ferquel | Émeline Perthame | Loïc Chartier | Jean-Claude George | Marie Varloud | Valérie Choumet
[1] S. Bonin,et al. The Impact of Telemedicine in the Diagnosis of Erythema Migrans during the COVID Pandemic: A Comparison with In-Person Diagnosis in the Pre-COVID Era , 2022, Pathogens.
[2] D. Brisson,et al. Borrelia burgdorferi strain and host sex influence pathogen prevalence and abundance in the tissues of a laboratory rodent host , 2022, Molecular ecology.
[3] K. Baldwin,et al. Early Disseminated Lyme Disease: Cranial Neuropathy, Meningitis, and Polyradiculopathy. , 2022, Infectious disease clinics of North America.
[4] M. Venetikou,et al. Climate Changes Exacerbate the Spread of Ixodes ricinus and the Occurrence of Lyme Borreliosis and Tick-Borne Encephalitis in Europe—How Climate Models Are Used as a Risk Assessment Approach for Tick-Borne Diseases , 2022, International journal of environmental research and public health.
[5] Ana M Ortega-Villa,et al. Characteristics and outcome of facial nerve palsy from Lyme neuroborreliosis in the United States , 2022, Annals of clinical and translational neurology.
[6] Y. Chaix,et al. Lyme neuroborreliosis in pediatrics: A retrospective, descriptive study in southwest France. , 2021, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[7] F. Strle,et al. Comparison of Lyme Disease in the United States and Europe , 2021, Emerging infectious diseases.
[8] D. Raoult,et al. Sexual Dimorphism and Gender in Infectious Diseases , 2021, Frontiers in Immunology.
[9] J. Paprocka,et al. Lyme Neuroborreliosis in Children , 2021, Brain sciences.
[10] R. Métras,et al. Exploratory Space–Time Analyses of Reported Lyme Borreliosis Cases in France, 2016–2019 , 2021, Pathogens.
[11] P. Godoy,et al. Use of Multiple Correspondence Analysis and K-means to Explore Associations Between Risk Factors and Likelihood of Colorectal Cancer: Cross-sectional Study , 2021, Journal of medical Internet research.
[12] J. Langley,et al. Lyme disease in children: Data from the Canadian Paediatric Surveillance Program. , 2019, Ticks and tick-borne diseases.
[13] G. Lina,et al. Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis. , 2019, Medecine et maladies infectieuses.
[14] V. Laugel,et al. Lyme neuroborreliosis in children: Report of nine cases and a review of the literature. , 2019, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[15] H. Wilking,et al. Incidence of notified Lyme borreliosis in Germany, 2013–2017 , 2018, Scientific Reports.
[16] B. H. Skogman,et al. Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome – a prospective cohort study , 2018, BMC Pediatrics.
[17] F. Strle,et al. Lyme borreliosis-from tick bite to diagnosis and treatment. , 2018, FEMS microbiology reviews.
[18] G. Rouleau,et al. Clinical presentation of Lyme disease in the higher-risk region of Quebec: a retrospective descriptive study. , 2018, CMAJ open.
[19] C. Strube,et al. Lyme borreliae prevalence and genospecies distribution in ticks removed from humans. , 2017, Ticks and tick-borne diseases.
[20] J. P. Davis,et al. Borrelia mayonii sp. nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper midwestern United States. , 2016, International journal of systematic and evolutionary microbiology.
[21] R. Sykes,et al. An estimate of Lyme borreliosis incidence in Western Europe† , 2016, Journal of public health.
[22] R. Berner,et al. Acrodermatitis Chronica Atrophicans. , 2016, The Journal of pediatrics.
[23] P. Lantos,et al. Chronic Lyme disease. , 2015, Infectious disease clinics of North America.
[24] Randall S. Nelson,et al. Update on Lyme Carditis, Groups at High Risk, and Frequency of Associated Sudden Cardiac Death — United States , 2014, Morbidity and Mortality Weekly Report.
[25] H. Kilpatrick,et al. The Relationship Between Deer Density, Tick Abundance, and Human Cases of Lyme Disease in a Residential Community , 2014, Journal of medical entomology.
[26] F. Strle,et al. Gender Disparity between Cutaneous and Non-Cutaneous Manifestations of Lyme Borreliosis , 2013, PloS one.
[27] T. Mach,et al. Lyme disease: review , 2012, Archives of medical science : AMS.
[28] F. Strle,et al. Lyme borreliosis , 2012, The Lancet.
[29] R. Nadelman,et al. Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. , 2011, Vector borne and zoonotic diseases.
[30] M. Neteler,et al. Lyme borreliosis in Europe. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[31] I. Santino,et al. Clinical and Serological Features of Patients with Suspected Lyme Borreliosis , 2011, International journal of immunopathology and pharmacology.
[32] J. Hercogová,et al. Identification of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in patients with erythema migrans , 2009, Folia Microbiologica.
[33] E. Skogvoll,et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial , 2008, The Lancet Neurology.
[34] Sébastien Lê,et al. FactoMineR: An R Package for Multivariate Analysis , 2008 .
[35] H. Pfister,et al. The Pathogenesis of Lyme Neuroborreliosis: From Infection to Inflammation , 2008, Molecular medicine.
[36] M. Greenacre,et al. Multiple Correspondence Analysis and Related Methods , 2006 .
[37] A. Flahault,et al. Lyme disease in France: a primary care-based prospective study , 2005, Epidemiology and Infection.
[38] F. Strle,et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis , 2005, Scandinavian journal of infectious diseases.
[39] A. Papa,et al. Borrelia valaisiana in Cerebrospinal Fluid , 2004, Emerging Infectious Diseases.
[40] M. L. Vieira,et al. First Isolation of Borrelia lusitaniae from a Human Patient , 2004, Journal of Clinical Microbiology.
[41] F. Strle,et al. Comparison of Erythema Migrans Caused by Borrelia afzelii and Borrelia garinii , 2004, Infection.
[42] B. Schwartz,et al. Occupational risk of Lyme disease: an epidemiological review , 2002, Occupational and environmental medicine.
[43] S. O'connell,et al. European Concerted Action on Lyme Borreliosis (EUCALB). , 1996 .
[44] Jean Côté,et al. Lyme Disease , 1991, International journal of dermatology.
[45] M. Feld,et al. Lyme carditis: an important cause of reversible heart block. , 1989, Annals of internal medicine.
[46] A. Steere,et al. The early clinical manifestations of Lyme disease. , 1983, Annals of internal medicine.
[47] A. Steere,et al. Lyme Carditis: Cardiac Abnormalities of Lyme Disease , 1980 .
[48] A. Steere,et al. Lyme borreliosis , 2016, Nature Reviews Disease Primers.
[49] G Stanek,et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[50] B. Florkin,et al. [Borrelia-associated lymphocytoma cutis]. , 2010, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[51] E. Diot,et al. [Lyme borreliosis: census of adult patients hospitalized in Indre-et-Loire (France), from the Hospital Discharge Data (1999-2006)]. , 2010, Revue d'epidemiologie et de sante publique.
[52] Elisabeth Catu. L’Institut national de la santé et de la recherche médicale (INSERM) , 1989 .